Logo Image
News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions PodcastShorts
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksState of the ScienceWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
News|Articles|December 18, 2024

Improving AAV Vector Quality with In-Process Monitoring of Capsid Formation

Author(s)Rentschler Biopharma SE

Whitepapers

Related Content

Leveraging 3DP In-Blister Tech for Real Time Release

ByAprecia
June 25th 2026

Sponsored Content

Addressing False Positives in Sequence Variant Analysis

ByCatalent
June 24th 2026

Sponsored Content

Expanding Horizons in Liquid Nasal Drug Development

ByCatalent
June 9th 2026

Sponsored Content

Innovative Screening Strategies for Cyclodextrin Interactions: AI, Computational Models, and Experimental Approaches

ByLigand
June 8th 2026

Sponsored Content

Becoming a Cornerstone of Fujifilm’s CDMO Strategy in Denmark

ByFUJIFILM Biotechnologies
June 5th 2026

Sponsored Content

Trending on Pharmaceutical Technology

1

FDA Updates Master Protocol: What Developers Need to Know

2

Pharma Fundamentals: Hold Times in Biopharmaceuticals

3

Merck KGaA Launches Saturnus Bio; Announces Awards

4

IPEC’s Excipient Information Package: A Standardized Communication Platform for Sharing Excipient Information as an Alternative to Questionnaires

5

Orally Dissolving Films: A Modern Solution for Convenient Drug Delivery

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us